Frontiers in Immunology (Aug 2022)

MR1-dependence of unmetabolized folic acid side-effects

  • Jeffry S. Tang,
  • Jeffry S. Tang,
  • Alissa Cait,
  • Reuben M. White,
  • Homayon J. Arabshahi,
  • David O’Sullivan,
  • David O’Sullivan,
  • Olivier Gasser,
  • Olivier Gasser

DOI
https://doi.org/10.3389/fimmu.2022.946713
Journal volume & issue
Vol. 13

Abstract

Read online

The fortification of flour with folic acid for the prevention of neural tube defects (NTD) is currently mandated in over eighty countries worldwide, hence compelling its consumption by the greater part of the world’s population. Notwithstanding its beneficial impact on rates of NTD, pervasive folic acid supplementation has invariably led to additive daily intakes reaching well beyond their original target, resulting in the circulation of unmetabolized folic acid. Associated idiopathic side-effects ranging from allergies to cancer have been suggested, albeit inconclusively. Herein, we hypothesize that their inconsistent detection and elusive etiology are linked to the in vivo generation of the immunosuppressive folic acid metabolite 6-formylpterin, which interferes with the still emerging and varied functions of Major Histocompatibility Complex-related molecule 1 (MR1)-restricted T cells. Accordingly, we predict that fortification-related adverse health outcomes can be eliminated by substituting folic acid with the bioequivalent folate vitamer 5-methyltetrahydrofolate, which does not break down into 6-formylpterin.

Keywords